EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications

Michael C Jin, Ian D Connolly, Karthik Ravi, Daniel G Tobert, Shannon M MacDonald, John H Shin

Neurosurgical Focus · 2024

DOI: 10.3171/2024.2.focus2417 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurosurgical Focus, 2024. Verfasst von Michael C Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurosurgery, Stanford University School of Medicine, Stanford, California. Hauptthemen laut MEDLINE: Chordoma, Fetal Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 146 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chordomas are tumors thought to originate from notochordal remnants that occur in midline structures from the cloves of the skull base to the sacrum. In adults, the most common location is the sacrum, followed by the clivus and then mobile spine, while in children a clival origin is most common. Most chordomas are slow growing. Clinical presentation of chordomas tend to occur late, with local invasion and large size often complicating surgical intervention. Radiation therapy with protons has been proven to be an effective adjuvant therapy. Unfortunately, few adjuvant systemic treatments have demonstrated significant effectiveness, and chordomas tend to recur despite intensive multimodal care. However, insight into the molecular underpinnings of chordomas may guide novel therapeutic approaches including selection for immune and molecular therapies, individualized prognostication of outcomes, and real-time noninvasive assessment of disease burden and evolution. At the genomic level, elevated levels of brachyury stemming from duplications and mutations resulting in altered transcriptional regulation may introduce druggable targets for new surgical adjuncts. Transcriptome and epigenome profiling have revealed promoter- and enhancer-dependent mechanisms of protein regulation, which may influence therapeutic response and long-term disease history. Continued scientific and clinical advancements may offer further opportunities for treatment of chordomas. Single-cell transcriptome profiling has further provided insight into the heterogeneous molecular pathways contributing to chordoma propagation. New technologies such as spatial transcriptomics and emerging biochemical analytes such as cell-free DNA have further augmented the surgeon-clinician’s armamentarium by facilitating detailed characterization of intra- and intertumoral biology while also demonstrating promise for point-of-care tumor quantitation and assessment. Recent and ongoing clinical trials highlight accelerating interest to translate laboratory breakthroughs in chordoma biology and immunology into clinical care. In this review, the authors dissect the landmark studies exploring the molecular pathogenesis of chordoma. Incorporating this into an outline of ongoing clinical trials and discussion of emerging technologies, the authors aimed to summarize recent advancements in understanding chordoma pathogenesis and how neurosurgical care of chordomas may be augmented by improvements in adjunctive treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChordomaFetal ProteinsHumansCarcinogenesisT-Box Domain ProteinsSkull Base NeoplasmsBrachyury Protein

Stichwörter der Autor:innen

chordomaepigenomegenomemolecular biologyneurosurgerytranscriptome

Substanzen

T-Box Domain ProteinsFetal ProteinsBrachyury Protein

Autor:innen und Institutionen

  • 1Department of Neurosurgery, Stanford University School of Medicine, Stanford, California.
  • Departments of2Neurosurgery.
  • 3Orthopedic Surgery, and.
  • 4Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.

Zitieren

APA

Jin, M. C., Connolly, I. D., Ravi, K., Tobert, D. G., MacDonald, S. M., & Shin, J. H. (2024). Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications. Neurosurgical Focus. https://doi.org/10.3171/2024.2.focus2417

Vancouver

Jin MC, Connolly ID, Ravi K, Tobert DG, MacDonald SM, Shin JH. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications. Neurosurgical Focus. 2024. doi:10.3171/2024.2.focus2417

BibTeX
@article{Jin2024,
  author = {Jin, Michael C and Connolly, Ian D and Ravi, Karthik and Tobert, Daniel G and MacDonald, Shannon M and Shin, John H},
  title = {Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications},
  journal = {Neurosurgical Focus},
  year = {2024},
  doi = {10.3171/2024.2.focus2417}
}
Kostenlos starten →